HM
Howard Marks (Oaktree Capital) disclosed decreased in NEOGENOMICS INC
Howard Marks (Oaktree Capital) filed a 13F change in NEOGENOMICS INC (64049MAB6) on 2026-05-19, covering period end 2026-03-31.
Action
Decreased
Capital
$1,242,713 reported value
Institutional 13F Signals1 evidence source
Why it matters
This signal is anchored to the SEC filing date while retaining the underlying 13F period end.